Abstract
Can Africa make 60% of its vaccines by 2040? That’s a tall order, as the travails of South African companies show
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
No reference metadata is available yet.
No additional external references are available.